Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2023

Open Access 01-12-2023 | Fibrodysplasia Ossificans Progressiva | Case report

Disease aggravation following surgery in a rare patient suspected to Fibrodysplasia (Myositis) ossificans progressiva: a case report

Authors: Amir Zarei, Foad Rahimi, Mehryar Khadem, Mansour Moradi, Khaled Rahmani

Published in: Journal of Medical Case Reports | Issue 1/2023

Login to get access

Abstract

Background

Fibrodysplasia ossificans progressiva (FOP) as a rare and heritable disorder with the infrequent genetic transmission of the condition is a catastrophic disorder of heterotopic ossification (HO) and a cause of extraskeletal bone formation in humans. Given the lack of effective treatment for this disease, the important point is to avoid aggravating factors such as bone biopsy, surgery, and intramuscular injection.

Case presentation

In this report, we present a 52-year-old female patient, Kurdish ethnic, suspected to FOP who had a surgical intervention on the second toe of the right foot, which subsequently, it caused further deterioration of the disease in the person including necrosis and amputation of the distal phalanx of the second toe.

Conclusions

Although, based on our investigation and the available scientific evidence, surgery may a cause for faster progression and worsening of the FOP disorder, but its proof requires further studies.
Literature
1.
go back to reference Pignolo RJ, Shore EM, Kaplan F. Fibrodysplasia ossificans progressiva: clinical and genetic aspects. Orphanet J Rare Dis. 2011;6(1):1–6.CrossRef Pignolo RJ, Shore EM, Kaplan F. Fibrodysplasia ossificans progressiva: clinical and genetic aspects. Orphanet J Rare Dis. 2011;6(1):1–6.CrossRef
2.
go back to reference Shore EM, et al. The genetics of fibrodysplasia ossificans progressiva. Clin Rev Bone Mineral Metabo. 2005;3(3):201–4.CrossRef Shore EM, et al. The genetics of fibrodysplasia ossificans progressiva. Clin Rev Bone Mineral Metabo. 2005;3(3):201–4.CrossRef
4.
go back to reference Pignolo RJ, Shore EM, Kaplan FS. Fibrodysplasia ossificans progressiva: diagnosis, management, and therapeutic horizons. Pediatric Endocrinol Rev. 2013;10(02):437. Pignolo RJ, Shore EM, Kaplan FS. Fibrodysplasia ossificans progressiva: diagnosis, management, and therapeutic horizons. Pediatric Endocrinol Rev. 2013;10(02):437.
5.
go back to reference Kaplan FS, et al. The phenotype of fibrodysplasia ossificans progressiva. Clin Rev Bone Mineral Metabol. 2005;3(3):183–8.CrossRef Kaplan FS, et al. The phenotype of fibrodysplasia ossificans progressiva. Clin Rev Bone Mineral Metabol. 2005;3(3):183–8.CrossRef
6.
go back to reference Kitterman JA, et al. Iatrogenic harm caused by diagnostic errors in fibrodysplasia ossificans progressiva. Pediatrics. 2005;116(5):e654–61.CrossRefPubMed Kitterman JA, et al. Iatrogenic harm caused by diagnostic errors in fibrodysplasia ossificans progressiva. Pediatrics. 2005;116(5):e654–61.CrossRefPubMed
7.
go back to reference Hair MS, Peeper JL, Metabolism M. The international fibrodysplasia ossificans progressiva association. Clin Rev Bone Mineral Metabol. 2005;3(3):267–9.CrossRef Hair MS, Peeper JL, Metabolism M. The international fibrodysplasia ossificans progressiva association. Clin Rev Bone Mineral Metabol. 2005;3(3):267–9.CrossRef
Metadata
Title
Disease aggravation following surgery in a rare patient suspected to Fibrodysplasia (Myositis) ossificans progressiva: a case report
Authors
Amir Zarei
Foad Rahimi
Mehryar Khadem
Mansour Moradi
Khaled Rahmani
Publication date
01-12-2023
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2023
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-023-04253-w

Other articles of this Issue 1/2023

Journal of Medical Case Reports 1/2023 Go to the issue